Quiero saber acerca de...

49536

Federal Register / Vol. 86, No. 169 / Friday, September 3, 2021 / Notices
healthcare systems or 710 LTC chains each, respectively, to implement adult immunization quality improvement interventions.
Summary of the Award
lotter on DSK11XQN23PROD with NOTICES1

Recipient: Council of Medical Specialty Societies CMSS and the Society for Post-Acute and Long-Term Care Medicine AMDA.
Purpose of the Award: The purpose of these awards is to increase COVID19, influenza, and routine vaccines in adults with chronic medical conditions e.g., COPD, asthma, diabetes, heart disease, cancer, and renal disease, increase workplace vaccination occupational health settings, and increase vaccination among adults working and residing in LTCFs through implementation of immunization quality improvement interventions.
CMSS will focus on activities leading to adoption of the Standards for Adult Immunization Practice in its 45
societies. AMDA will focus on the same with its affiliate organization, the Foundation for Post-Acute and LongTerm Care Medicine. CMSS and AMDA
will develop/update vaccine policy statements, develop/promote continuing education on adult immunization for their membership, and award funds to up to 7 subspecialty societies for CMSS and to the Foundation for AMDA to systematize routine delivery of adult immunizations. CMSS-funded subspecialty societies and AMDAs Foundation should fund staff at the national level and in regional chapters to update vaccination policies and encourage use of adult vaccinations as quality measures. CMSS subspecialty societies and AMDAs Foundation should also contract with 710
healthcare systems or 710 LTC chains each, respectively, to implement adult immunization quality improvement interventions.
Amount of Award: $26,000,000 in Federal Fiscal Year FFY 2021 funds, and an estimated total of $66,000,000
over the five-year period of performance.
Period of Performance: September 30, 2021 through September 29, 2026.
Dated: August 30, 2021.
Joseph I. Hungate III, Deputy Director, Office of Financial Resources, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
FR Doc. 202119050 Filed 9221; 8:45 am BILLING CODE 416318P

VerDate Sep<11>2014

16:55 Sep 02, 2021

Jkt 253001

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and Prevention Humanitarian Exemption Approved for All Afghan Evacuees Subject to CDCs Global Testing Order Centers for Disease Control and Prevention CDC, Department of Health and Human Services HHS.
ACTION: Notice.
AGENCY:

The Centers for Disease Control and Prevention CDC, located within the Department of Health and Human Services HHS, announces a blanket humanitarian exemption to the agencys Requirement for Negative PreDeparture COVID19 Test Result for individuals relocating to the United States from Afghanistan, including U.S.
citizens, lawful permanent residents LPRs, third country nationals, and Afghans at risk, including Afghan Special Immigrant Visa SIV applicants.
DATES: This exemption went into effect on August 15, 2021.
FOR FURTHER INFORMATION CONTACT:
Tiffany Brown, Deputy Chief of Staff, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS
H2110, Atlanta, GA 30329. Phone:
4046397000. Email: cdcregulations@
cdc.gov.
SUPPLEMENTARY INFORMATION: On January 12, 2021, CDC announced an Order requiring all air passengers arriving to the U.S. from a foreign country to get tested no more than 3
days before their flight departs and to present the negative result or documentation of having recovered from COVID19 to the airline before boarding the flight.
In August 2021, the U.S. Department of State DOS issued a series of Security Alerts for Afghanistan due to increased Taliban activity throughout the country, including the capital of Kabul. In response to a request from DOS on August 15, 2021, CDC and the U.S.
Department of Health and Human Services HHS granted a blanket humanitarian exemption to CDCs Order to expedite the evacuation of U.S.
citizens, lawful permanent residents LPRs, third country nationals, and Afghans at risk, including Afghan Special Immigrant Visa SIV applicants, while adhering to COVID19 mitigation guidance issued by CDC.
The exemption, which is being administered by DOS and cooperating federal and state agencies, was granted with the following conditions: 1 The CDC Order requiring mask use for SUMMARY:

PO 00000

Frm 00033

Fmt 4703

Sfmt 9990

passengers and crew on air conveyances bound for the United States should be followed to the extent possible; 2 all efforts should be made to test and provide test documentation to the traveler at a transit location prior to arrival in the United States that can be presented upon arrival, and if this cannot be done, individuals travelers arriving are required to undergo COVID19 testing immediately upon arrival to the first port of entry in the United States; 3 individuals who test positive are required to isolate prior to continuing on commercial transportation to their final destination;
and 4 family members of those testing positive may require adhering to selfquarantine recommendations as stipulated by CDC or state and local health authorities at the arrival location.
In addition, all Afghan evacuees covered by the exemption must also agree to comply with relevant CDC posttravel public health guidance including:
Watch their health for symptoms of COVID19. If they become ill during the flight to the United States or while in a U.S. airport, they should immediately report their illness.
Take all the necessary steps to protect themselves and others during travel, such as wearing a mask to keep their nose and mouth covered when in public settings, including on public transportation and in airports and other transportation hubs until they arrive at their final destination.
Avoid being around people who are at increased risk for severe illness for 14
days.
Follow all federal, state, territorial, and local requirements and all other public health measures for preventing community transmission of COVID19.
Authority: The CDC Director is issuing this Notice pursuant to Sections 361 of the Public Health Service Act, 42
U.S.C. 264, and implementing regulations at 42 CFR 71.20 and 71.31b.
Dated: August 31, 2021.
Sherri Berger, Chief of Staff, Centers for Disease Control and Prevention.
FR Doc. 202119089 Filed 9221; 8:45 am BILLING CODE 416318P

E:FRFM03SEN1.SGM

03SEN1